Single-use assemblies market to top $20.87 billion by 2030

The Business Research Company says the global single-use assemblies market is set for rapid growth, rising from $7.43 billion in 2025 to $20.87 billion by 2030. The report points to biopharmaceutical expansion, life science R&D and contamination-control needs as the main drivers, with North America leading in 2025.

Why it matters: - Single-use assemblies are becoming core infrastructure for biopharmaceutical manufacturing because they cut contamination risk, reduce cleaning needs and support faster production. - The market’s projected growth signals continued investment in disposable bioprocessing tools and more flexible manufacturing systems across pharma.

What happened: - The Business Research Company released its Single-Use Assemblies Market Report 2026, covering market size, trends and a global forecast through 2035. - The report estimates the market will grow from $7.43 billion in 2025 to $9.16 billion in 2026. - The report forecasts the market will reach $20.87 billion by 2030. - North America was the largest regional market in 2025.

The details: - The report says the 2025-to-2026 expansion reflects a 23.3% compound annual growth rate. - The forecast period through 2030 implies a 22.8% CAGR. - Growth drivers include biopharmaceutical manufacturing expansion, wider use of disposable bioprocessing equipment, growth in contract manufacturing, demand for operational flexibility and advanced polymer materials. - Future growth is tied to investments in biologics manufacturing, demand for adaptable production facilities, cell and gene therapy pipelines, sustainability concerns in bioprocessing and adoption in emerging economies. - The report identifies key trends including modular single-use systems, customized assembly configurations, sterile fluid transfer products, broader bioprocessing use and tighter contamination controls. - Single-use assemblies are pre-assembled, sterilized units made of integrated plastic components for sterile fluid transfer in pharmaceutical manufacturing. - These systems are designed to reduce cross-contamination and leakage, lower downtime, cut operational costs and improve efficiency. - The report says single-use assemblies help connect medical and laboratory instruments and support streamlined bioprocessing workflows. - Regional coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report notes North America’s lead is supported by advanced pharmaceutical infrastructure and heavy investment in biopharmaceutical innovation. - Asia-Pacific is expected to grow faster as flexible manufacturing and healthcare infrastructure expand.

Between the lines: - The report frames single-use assemblies as part of a broader shift toward faster, cleaner and more modular pharmaceutical production. - The biopharma and R&D backdrop suggests demand is being shaped by both manufacturing scale-up and the push for more targeted therapies. - The inclusion of sustainability as a growth factor shows the sector is balancing disposable systems with pressure to reduce waste and improve process efficiency.

What's next: - The Business Research Company expects modular systems, tailored configurations and sterile fluid transfer products to remain central to market growth. - Emerging economies may become a bigger demand source as more manufacturers adopt single-use technology. - The company also added 2026 report features including market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics. - More information is available in the full report and a free sample.